Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRP | O00591 | 2/20 | 0.30 |
| ▸ | GABRD | O14764 | 2/20 | 0.30 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.30 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.30 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.30 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.30 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.30 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.30 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.30 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.30 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.30 |
| ▸ | GABRE | P78334 | 2/20 | 0.30 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.30 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.30 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.30 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14645902 | 0.79 | TSHR (0.34) | — | |
| SCHEMBL8678989 | 0.75 | — | — | |
| SCHEMBL14218181 | 0.75 | ELANE (0.34) | — | |
| SCHEMBL19361146 | 0.74 | — | — | |
| Hydrochloric Acid SCHEMBL3507717 | 0.72 | TSHR (0.33) | — | |
| SCHEMBL11396697 | 0.70 | — | — | |
| SCHEMBL2678654 | 0.70 | TSHR (0.33) | — | |
| SCHEMBL295903 | 0.68 | — | — | |
| SCHEMBL13647266 | 0.68 | TSHR (0.38) | — | |
| SCHEMBL28333588 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3038992-B1 | NOVEL FIBERS, METHODS FOR THEIR PREPARATION AND USE IN THE MANUFACTURE OF REINFORCED ELEMENTS | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2019-10-30 | — | — | EP | disclosed |
| CN-105492406-B | New fiber, preparation method and the purposes in manufacture reinforcing element | 建筑研究和技术有限公司 | 2018-11-16 | — | — | CN | disclosed |
| US-10065887-B2 | Fibers, methods for their preparation and use in the manufacture of reinforced elements | CONSTRUCTION RESEARCH & TECHNOLOGY, GMBH (DE) | 2018-09-04 | — | — | US | disclosed |
| US-20180022980-A1 | USE OF CSH-SEED MODIFIED FIBERS IN OIL FIELD APPLICATIONS | BASF CONSTRUCTION SOLUTIONS GMBH (DE) | 2018-01-25 | — | — | US | disclosed |
| EP-3262009-A1 | USE OF CSH-SEED MODIFIED FIBERS IN OIL FIELD APPLICATIONS | BASF SE (DE) | 2018-01-03 | — | — | EP | disclosed |
| WO-2016135182-A1 | USE OF CSH-SEED MODIFIED FIBERS IN OIL FIELD APPLICATIONS | BASF SE (DE) | 2016-09-01 | — | — | WO | disclosed |
| US-20160194245-A1 | NOVEL FIBERS, METHODS FOR THEIR PREPARATION AND USE IN THE MANUFACTURE OF REINFORCED ELEMENTS | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2016-07-07 | — | — | US | disclosed |
| EP-3038992-A1 | NOVEL FIBERS, METHODS FOR THEIR PREPARATION AND USE IN THE MANUFACTURE OF REINFORCED ELEMENTS | Construction Research & Technology GmbH (DE) | 2016-07-06 | — | — | EP | disclosed |
| CN-105492406-A | Novel fibers, methods for their preparation and use in the manufacture of reinforced elements | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH | 2016-04-13 | — | — | CN | disclosed |
| EP-2842921-A1 | Novel fibers, methods for their preparation and use in the manufacture of reinforced elements | Construction Research & Technology GmbH (DE) | 2015-03-04 | — | — | EP | disclosed |
| US-20040019046-A1 | Phenylacetamido-pyrazole derivatives and their use as antitumor agents | PHARMACIA ITALIA SPA (IT) | 2004-01-29 | — | — | US | disclosed |
| EP-1345909-A1 | PHENYLACETAMIDO-PYRAZOLE DERIVATIVES AND THEIR USE AS ANTITUMOR AGENTS | Pharmacia Italia S.p.A. (IT) | 2003-09-24 | — | — | EP | disclosed |
| WO-2002048114-A1 | PHENYLACETAMIDO- PYRAZOLE DERIVATIVES AND THEIR USE AS ANTITUMOR AGENTS | PHARMACIA ITALIA S.P.A. (IT) | 2002-06-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040019046-A1 | Phenylacetamido-pyrazole derivatives and their use as antitumor agents | DCK, CCNK, CDK2 | GABRP 2720/4885GABRD 4062/4885GABRA1 4068/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.